Elsevier

Biochimie

Volume 88, Issue 9, September 2006, Pages 1091-1098
Biochimie

Role of MAPKs in development and differentiation: lessons from knockout mice

https://doi.org/10.1016/j.biochi.2006.06.003Get rights and content

Abstract

The ERK, p38MAPK, JNK mitogen-activated protein kinases (MAPKs) are intracellular signaling pathways that play a pivotal role in many essential cellular processes such as proliferation and differentiation. These cascades are activated by a large variety of stimuli and display a high degree of homology. So far, seven MAPK isoforms have been invalidated in mice leading to the discovery of their important functions in development and differentiation. As we could expect because of their multiple and specific properties in vitro, knockout (KO) of MAPK pathways leads to distinct phenotypes in mice. Surprisingly, into a given cascade, KOs of the various isoforms assign specific non-redundant biological functions to each isoform, without compensation by the others. These results emphasize the notion that, although initiated by the same external stimuli, these intracellular cascades activate kinase isoforms each with its own specific role.

Introduction

Cells encounter an enormous variety of signals in their environment and must respond to each stimulus appropriately with changes in their genetic programs. Many of these external signals are transduced by a highly conserved eukaryotic signaling mechanism, the mitogen-activated protein kinase (MAPK) cascades. MAPKs participate in signal transduction pathways that control intracellular events including acute responses to hormones and major developmental changes in organisms.

In mammals, at least four distinct groups of MAPKs have been recognized: extracellular signal-regulated kinases (ERKs) 1 and 2 (ERK 1/2 or p44/p42), c-Jun amino-terminal kinases or stress-activated protein kinases (JNK/SAPK) 1–3, p38MAPK α, β, γ and δ, and ERK5 (for review see [1], [2]). Most of our present knowledge comes from the study of three groups of MAPKs: ERK1/2; JNK1/2 and p38MAPK. These serine/threonine kinases are regulated by phosphorylation cascades organized in specific modules. All modules comprise two additional protein kinases activated in series and leading to activation of a specific MAP kinase: a MAP kinase kinase (MAPKK or MAP2K), represented by MEK or MKK proteins, which phosphorylates a specific MAPK, and a MAP kinase kinase kinase (MAPKKK or MAP3K), represented by Raf and MEKK proteins, which phosphorylates a specific MAPKK (Fig. 1).

Numerous in vitro studies, using specific chemical inhibitors, have shed light on physiological roles of MAPKs and their signaling pathways. However, inhibitors are rarely specific for one isoform but rather exert their activity on the upstream kinases. The gene-targeting technology has contributed to our knowledge of MAPK signaling cascades in vivo. In particular, analysis of knockouts (KOs) of MAPKs, activators of MAPKs, and substrates of MAPKs have revealed surprising and intriguing results regarding cell and development-specific functions of MAPK signaling cascades. Interestingly, it points out important differences between highly homolog isoforms. In this review, we focus on the role of ERK1/2, JNK1/2, p38MAPK and ERK5 in development and metabolism based on MAPK KO mice phenotypes.

MAPK pathways are activated by a variety of stimuli, but it is generally assumed that ERK1/2 are activated by mitogens such as growth factors, serum, and phorbol esters, while JNK and p38 MAPK respond to stress such as osmotic stress, UV and cytokines (for review see [3]). Although each MAPK presents unique characteristics, a number of features are shared by the MAPK pathways studied to date.

The specificity of activation and function of MAPK signaling modules is determined, in part, by scaffold proteins that create multi-enzyme complexes. These scaffold proteins appear to facilitate MAPK activation, in response to specific physiological stimuli, and to protect the bound MAPK module against activation by irrelevant stimuli. This pivotal regulation is mainly carried out by scaffolding inhibitor and adaptor proteins that enhance, decrease or redirect the signal flux (for review see [4], [5]).

Once activated MAPKs phosphorylate a large panel of substrates on serine and threonine most often followed by proline residues. One subset of MAPKs targets is composed of protein kinases called MAPK-activated protein kinases (MKs). MKs play a crucial role in a variety of biological functions in response to mitogens or stress. In addition to enhancing gene expression via intermediary kinases that increase the accessibility of DNA, MAPKs also directly phosphorylate a second subset of proteins, transcription factors and regulate their activities.

Section snippets

Properties

ERK1 and ERK2, 44 and 42 kDa, are 83% identical, with most differences observed outside the kinase core [6], [7]. They are expressed to varying extent in all tissues, including terminally differentiated cells (for review see [2]). No in vitro evidence has been shown so far for a differential role of ERK1 and ERK2. Both isoforms are strongly activated by growth factors, serum, and phorbol esters and to a lesser degree by ligands for heterotrimeric G protein-coupled receptors, cytokines,

Properties

Cloning of jnk was performed by two groups and led to identification of several isoforms [21], [22]. jnk1–3, also known as SAPKγ, SAPKα, and SAPKβ, exist as 10 or more spliced forms. They are ubiquitous, although JNK3 is primarily present in brain. They are identified as SAPKs because their activities strongly increase in response to cytokines, UV irradiation, growth factor deprivation, and agents that interfere with DNA and protein synthesis. In addition, JNK is activated by ligands for some G

Properties

p38α (p38) was first isolated as a 38-kDa protein rapidly tyrosine phosphorylated in response to lipopolysaccharide (LPS) stimulation [36], [37]. Cloning of p38 MAPK led to identification of four isoforms: p38α p38β [38] p38γ(ERK6, SAPK3) [39], [40] and p38δ(SAPK4) [41], [42]. While p38α and p38β are ubiquitous, p38γ and p38δ are specifically expressed in few tissues. All p38 MAPKs are activated predominantly by the MAPKKs MKK3 and MKK6 [43] and by phosphorylation of threonine 180 and tyrosine

ERK5

The regulation and function of ERK5 have been much less studied than other MAPKs. However, several articles have demonstrated that ERK5 is activated by mitogens [56] and that this activation is required for growth factor induced proliferation [57]. Chao et al. [58] identified a direct link between the activation of MEKK3 and subsequent activation of ERK5 via MEK5 suggesting a linear cascade for ERK5 activation: MEKK3-MEK5-ERK5. Among the ERK5 substrates is the family of the myocyte enhancer

Conclusion

MAPK pathways have been implicated in numerous critical functions in vitro and yet among the 10 isoforms of MAPKs invalidated so far only three of them are embryonic lethal suggesting that compensation between the isoforms is happening during the development. Conversely, while activated by the same stimuli and despite their high homology MAPK isoforms have different functions (Table 1). Lessons from KOs mice are of valuable meaning to understand the role of proteins in development. However,

Acknowledgements

We thank Jean François Tanti for carefully reading the manuscript. This work was supported by Inserm, Université de Nice Sophia Antipolis, Foundation Bettencourt-Schueller and ARC (grant no. 4525). M. Aouadi and L. Caron were supported by a fellowship Inserm-Institut de Recherche International Servier-Provence Alpes Côte d'Azur, La Ligue Départementale de Lutte Contre le Cancer (M.A.) and La Ligue Nationale Contre le Cancer (L.C.). F. Bost is a CNRS investigator.

References (66)

  • K. Sabapathy et al.

    Defective neural tube morphogenesis and altered apoptosis in the absence of both JNK1 and JNK2

    Mech. Dev.

    (1999)
  • D.D. Yang et al.

    Differentiation of CD4+ T cells to Th1 cells requires MAP kinase JNK2

    Immunity

    (1998)
  • C.Y. Kuan et al.

    The Jnk1 and Jnk2 protein kinases are required for regional specific apoptosis during early brain development

    Neuron

    (1999)
  • J. Han et al.

    Endotoxin induces rapid protein tyrosine phosphorylation in 70Z/3 cells expressing CD14

    J. Biol. Chem.

    (1993)
  • Y. Jiang et al.

    Characterization of the structure and function of a new mitogen-activated protein kinase (p38beta)

    J. Biol. Chem.

    (1996)
  • Z. Li et al.

    The primary structure of p38 gamma: a new member of p38 group of MAP kinases

    Biochem. Biophys. Res. Commun.

    (1996)
  • Y. Jiang et al.

    Characterization of the structure and function of the fourth member of p38 group mitogen-activated protein kinases, p38delta

    J. Biol. Chem.

    (1997)
  • S. Kumar et al.

    Novel homologues of CSBP/p38 MAP kinase: activation, substrate specificity and sensitivity to inhibition by pyridinyl imidazoles

    Biochem. Biophys. Res. Commun.

    (1997)
  • H. Enslen et al.

    Selective activation of p38 mitogen-activated protein (MAP) kinase isoforms by the MAP kinase kinases MKK3 and MKK6

    J. Biol. Chem.

    (1998)
  • K. Tamura et al.

    Requirement for p38alpha in erythropoietin expression: a role for stress kinases in erythropoiesis

    Cell

    (2000)
  • R.H. Adams et al.

    Essential role of p38alpha MAP kinase in placental but not embryonic cardiovascular development

    Mol. Cell

    (2000)
  • L. de Angelis et al.

    Regulation of vertebrate myotome development by the p38 MAP kinase-MEF2 signaling pathway

    Dev. Biol.

    (2005)
  • T.H. Chao et al.

    MEKK3 directly regulates MEK5 activity as part of the big mitogen-activated protein kinase 1 (BMK1) signaling pathway

    J. Biol. Chem.

    (1999)
  • S.J. Sohn et al.

    ERK5 MAPK regulates embryonic angiogenesis and acts as a hypoxia-sensitive repressor of vascular endothelial growth factor expression

    J. Biol. Chem.

    (2002)
  • Z. Chen et al.

    MAP kinases

    Chem. Rev.

    (2001)
  • G. Pearson et al.

    Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions

    Endocr. Rev.

    (2001)
  • W. Kolch et al.

    MAPK signalling through scaffolds and inhibitors

    Nat. Rev. Mol. Cell Biol.

    (2005)
  • K. Yoshioka

    Scaffold proteins in mammalian MAP kinase cascades

    J. Biochem. (Tokyo)

    (2004)
  • T.G. Boulton et al.

    Identification of multiple extracellular signal-regulated kinases (ERKs) with antipeptide antibodies

    Cell Regul.

    (1991)
  • G. Pages et al.

    Defective thymocyte maturation in p44 MAP kinase (Erk 1) knockout mice

    Science

    (1999)
  • T. Nekrasova et al.

    ERK1-deficient mice show normal T cell effector function and are highly susceptible to experimental autoimmune encephalomyelitis

    J. Immunol.

    (2005)
  • J.C. Selcher et al.

    Mice lacking the ERK1 isoform of MAP kinase are unimpaired in emotional learning

    Learn. Mem.

    (2001)
  • F. Bost et al.

    Retinoic acid activation of the ERK pathway is required for embryonic stem cell commitment into the adipocyte lineage

    Biochem. J.

    (2002)
  • Cited by (0)

    1

    Present address: Inserm U626, faculté de médecine La Timone, 27, boulevard Jean-Moulin, 13385 Marseille cedex 05, France.

    View full text